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Data from the past decade underscore the
public health relevance of studying workplace
reproductive hazards. In 2003, Census data
indicated that nearly 55% of children were
born to working mothers (U.S. Census
Bureau 2003a), and 62% of working men and
women were of reproductive age (U.S. Census
Bureau 2003b). The goal of occupational
reproductive research is to effectively study
the many toxicants, physical agents, and bio-
mechanical and psychosocial stressors that
may constitute reproductive hazards in the
workplace. The difﬁculty of this task is com-
pounded by several realities: the intrinsic
methodologic limitations of both animal and
human observational studies, the impact of
mixed and multiple exposures, and complex
work environments, both traditional and tran-
sitional. Although the main objective of occu-
pational reproductive researchers and
clinicians is to prevent recognized adverse
reproductive outcomes, research has expanded
to include a broader spectrum of health out-
comes, such as breast cancer and the nature
and timing of menopause and latent adverse
reproductive effects.
The National Occupational Research
Agenda (NORA) was formed in 1996, when
the National Institute for Occupational Safety
and Health (NIOSH) and its university, fed-
eral, industry, and labor partners unveiled
the agenda as a framework to guide occupa-
tional safety and health research into the next
decade. Approximately 500 organizations and
individuals outside NIOSH provided input
into the development of the agenda. The
NORA process resulted in a remarkable con-
sensus about the top 21 research priorities,
including reproductive health research. The
Reproductive Health Research Team (RHRT)
included individuals engaged in basic labora-
tory research, epidemiology, risk communica-
tion, and public health and collaborated with
other NORA teams engaged in exposure
assessment, control technologies, and interven-
tion effectiveness. In this report we describe a
broad domain of activities that are relevant to
public health applications.
A Decade of Progress
The team’s initial achievements focused on
prioritizing reproductive toxicants for further
research, promoting the study of high-priority
toxicants, and promoting occupational expo-
sure assessment in existing surveillance studies.
Recently, the team established a national
occupational reproductive health research
agenda (Lawson et al. 2003) to recommend
future research directions to reduce the inci-
dence of adverse reproductive health out-
comes. This work can be accomplished with
an interdisciplinary research program that
identiﬁes reproductive hazards, their mecha-
nism of toxicant action, and target popula-
tions. To lay the groundwork for a better
understanding of occupational reproductive
health issues, the team sponsored a sympo-
sium on the clinical, epidemiologic, and expo-
sure assessment aspects of occupational
reproductive exposures at the 2003 Teratology
Society Annual meeting (Grajewski et al.
2005).
Prioritizing reproductive toxicants for fur-
ther study. Although more than 84,000 chemi-
cal compounds are in the workplace (2,000
new chemicals each year) (Endocrine Disruptor
Screening and Testing Advisory Committee
1998), only about 4,000 have been evaluated
for reproductive toxicity [U.S. Environmental
Protection Agency (EPA) 1998]. Several
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The initial goal of occupational reproductive health research is to effectively study the many
toxicants, physical agents, and biomechanical and psychosocial stressors that may constitute repro-
ductive hazards in the workplace. Although the main objective of occupational reproductive
researchers and clinicians is to prevent recognized adverse reproductive outcomes, research has
expanded to include a broader spectrum of chronic health outcomes potentially affected by repro-
ductive toxicants. To aid in achieving these goals, the National Institute for Occupational Safety
and Health, along with its university, federal, industry, and labor colleagues, formed the National
Occupational Research Agenda (NORA) in 1996. NORA resulted in 21 research teams, including
the Reproductive Health Research Team (RHRT). In this report, we describe progress made in the
last decade by the RHRT and by others in this ﬁeld, including prioritizing reproductive toxicants
for further study; facilitating collaboration among epidemiologists, biologists, and toxicologists;
promoting quality exposure assessment in ﬁeld studies and surveillance; and encouraging the design
and conduct of priority occupational reproductive studies. We also describe new tools for screening
reproductive toxicants and for analyzing mode of action. We recommend considering outcomes
such as menopause and latent adverse effects for further study, as well as including exposures such
as shift work and nanomaterials. We describe a broad domain of scholarship activities where a
cohesive system of organized and aligned work activities integrates 10 years of team efforts and pro-
vides guidance for future research. Key words: communication, environmental exposure, occupa-
tional exposure, reproduction, research design, risk factors. Environ Health Perspect 114:435–441
(2006). doi:10.1289/ehp.8458 available via http://dx.doi.org/ [Online 26 October 2005]NORA team members participated in the
expert panel that prioritized chemical repro-
ductive toxicants identified by the National
Toxicology Program (NTP), using an objective
and systematic method (Moorman et al. 2000).
The method linked toxicity data with data on
the population potentially at risk based on the
estimated number of workers exposed and
production data. Using this method, a prior-
ity matrix was developed that combined rank-
ings for toxicity and number of workers at
risk into categories of low, medium, and high.
The panel found that the chemicals with the
highest priority for human reproductive
health studies were dibutyl phthalate, boric
acid, tricresyl phosphate, and N,N-dimethyl-
formamide. Chemicals with high/medium
rankings included acrylamide, N-hydrox-
ymethylacrylamide, 4-chloronitrobenzene,
2-butoxyethanol, oxalic acid, bisphenol A,
and ethylene glycol.
Systematic prioritization of chemicals for
study helps ensure efficient use of research
funds. Many more chemicals remain to be
studied, and the rankings should be periodi-
cally updated to incorporate new toxicity and
usage data. Future priorities are likely to be
affected by improved exposure information
coming from biomonitoring data from the
Centers for Disease Control and Prevention’s
(CDC) National Health and Nutrition
Examination Survey (NHANES).
Promoting the study of prioritized toxi-
cants. Prioritized toxicants have been the
focus of new studies initiated both inside and
outside of NIOSH. Federal spending for
occupational reproductive health research, in
general, increased substantially and collabora-
tively during 1996–2003. For example, total
NIOSH expenditures in the area of reproduc-
tive health increased from $750,000 in 1996
to > $4 million in 2004, for internal NIOSH
research and for funding of research grants
outside of NIOSH. As another example, an
endocrine disruptor grants announcement
was cosponsored by NIOSH, the National
Institute of Environmental Health Sciences
(NIEHS), the U.S. EPA, and the National
Cancer Institute (NCI).
To promote the study of high-priority
reproductive toxicants, the NORA team
established a partnership with the Center
for the Evaluation of Risks to Human
Reproduction (CERHR). NTP and NIEHS
established CERHR in 1998 to serve as an
environmental health resource to the public
and to regulatory and health agencies.
Located in Research Triangle Park, North
Carolina, the center’s staff and expert panel
members represent multiple disciplines,
including genetics, biology, toxicology, chem-
istry, industrial hygiene, biostatistics, epi-
demiology, and various medical specialties.
The center provides scientifically based,
uniform assessments of the potential for
adverse effects on reproduction and develop-
ment caused by agents to which humans may
be exposed. This is accomplished through rig-
orous evaluations of the scientiﬁc literature by
independent panels of scientists and through
summarized reports in terms that can be
understood by those who are not scientiﬁcally
trained. Such evaluations encompass health
effects including impaired fertility, adverse
pregnancy outcomes, birth defects, and post-
natal functional deficits. Nominations of
chemicals to the CERHR are solicited from
the public and the scientific community.
Recent monographs on 1-bromopropane,
2-bromopropane, ethylene glycol, propylene
glycol, and phthalates are available on the
CERHR website (CERHR 2005b).
Internal NIOSH research is using field
studies, exposure assessment, and laboratory
biomonitoring to study several prioritized
reproductive toxicants. One study is evaluat-
ing worker exposure to phthalate compounds,
which are used as plasticizers and solvents in
many industrial and consumer goods, such
as flexible polyvinyl chloride, nail polish,
fragrances, adhesives, and lacquers. In an
NHANES report, phthalate levels were found
to be elevated in the urine of women of repro-
ductive age compared with levels for men
(Silva et al. 2004). Several phthalates have
demonstrated adverse reproductive effects,
including male reproductive toxicity, in
animals (CERHR 2000). There are virtually
no published data available on the extent of
phthalate exposures among working popula-
tions who use or are exposed to these chemi-
cals, although thousands of workers may be
exposed. Combining the ﬁeld research exper-
tise of NIOSH and laboratory expertise of the
National Center for Environmental Health at
the CDC, this project will measure levels of
urinary metabolites of phthalates among
workers in a variety of industries to identify
populations for epidemiologic research.
Another NIOSH internal study is evaluat-
ing the extent of exposures to 1-bromopropane,
a solvent and degreaser that is proposed to
replace ozone-depleting solvents in metal and
electronics industries. Potential dermal and
inhalation exposure to 1-bromopropane can
occur during metal degreasing, precision clean-
ing, and use of bromopropane-containing
adhesives. 1-Bromopropane was nominated by
NIOSH and selected for evaluation by
CERHR based primarily on documented evi-
dence of worker exposures and published evi-
dence of male and female reproductive and
developmental toxicity in rodents (CERHR
2004), although human reproductive studies
were lacking. The exposure assessment consists
of walk-through surveys, company record
audits, industrial hygiene assessments (personal
sampling as well as area monitoring), and
measurements of exhaled breath (parent com-
pound) and urinary metabolites. Another study
is examining occupational exposure to acry-
lamide, used in the production of polymers and
gels found in a wide variety of consumer prod-
ucts and as a cement binder. The NTP and
CERHR have concluded that there is some
concern for adverse reproductive and develop-
mental effects from occupational exposure lev-
els of acrylamide (CERHR 2005a). Workplace
exposure monitoring, reproductive and neuro-
logic health assessments, and biomonitoring
will be conducted in the NIOSH study.
Boron is ubiquitous in nature and is used
in a wide array of consumer goods. However,
animal reproductive toxicity data and limited
epidemiologic data indicate that boric acid
and borax can cause reproductive toxicity in
humans, and effects on sperm development
have been observed in male animals (Moore
et al. 1997). With funding from a NIOSH
grant under NORA, investigators at the
University of California at Los Angeles are
collaborating with scientists in China to con-
duct a study of approximately 1,400 boron-
exposed workers and unexposed workers in
China. Laboratory measurements for this
study integrated new sperm DNA integrity
measures, conventional semen quality meas-
ures, hormones, blood-urine-semen boron,
and boron levels in food, drinking water, and
the workplace. Currently, analysis of data and
biologic specimens is continuing.
Although 3% of babies in the United
States are born with a major birth defect
(CDC 1995), the cause of > 40% of birth
defects remains unknown (Holmes 1997).
Traditionally, few etiologic studies of birth
defects have addressed parental occupational
exposures, even though thousands of chemi-
cals are being used in the workplace by men
and women of reproductive age. To have a
sufﬁcient sample size to conduct research on
speciﬁc types of birth defects, it is important
to have collaboration among multiple research
sites. The CDC has established the Centers
for Birth Defects Research and Prevention in
Arkansas, California, Iowa, Massachusetts,
North Carolina, New Jersey, New York,
Texas, and Utah. These centers, along with
the Metropolitan Atlanta Congenital Defects
Program, have participated in the National
Birth Defects Prevention Study (NBDPS), the
largest case–control study of birth defects ever
undertaken. NIOSH scientists are collaborat-
ing with the CDC National Center on Birth
Defects and Developmental Disabilities and
NCI to conduct an occupational exposure
assessment using parental occupational infor-
mation collected as part of the NBDPS.
Parental exposures to solvents, metals, and
pesticides will be analyzed, and estimated
exposure among cases and controls will be
compared.
Lawson et al.
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Rethinking outcomes and exposures. The
changing nature of work and the work envi-
ronment and the emerging technologies in
reproductive biology and exposure assessment
are leading us to rethink approaches to study-
ing exposures and traditional reproductive
health outcomes. It remains important to
emphasize that the spectrum of reproductive
health outcomes includes not only women of
childbearing potential but also all working
women, all working men, and all of their
potential offspring. Clinical outcomes among
workers should include sexual dysfunction,
infertility, pregnancy loss, male:female sex
ratios of pregnancies, aberrations of fetal
growth, preterm births, clinical manifestations
of endocrine disruptions (e.g., early menopause
and andropause), and reproductive organ and
endocrine-mediated neoplasms. Outcomes
among offspring include congenital malfor-
mations, developmental challenges, infant and
childhood neoplasms, and potentially adult
reproductive health outcomes.
An example of an emerging end point for
the assessment of adverse reproductive health in
women is entry into the menopausal transition.
In addition to providing a marker of ovarian
senescence, the transition to menopause marks
the beginning of a series of hormonal changes
of biologic and clinical importance. Both early
and late menopause are well established as asso-
ciated with chronic health challenges (Gordon
et al. 1978; Lindquist et al. 1979; Trichopoulos
et al. 1972). A more recent study suggests that
menopause is associated with a decline in grip
and pinch strength (Kurina et al. 2004). From a
research perspective, a standard deﬁnition of
the start of the menopausal transition would
allow important comparisons across occupa-
tional health studies; some efforts have been
made in this area (Lisabeth et al. 2004). Age
at menarche, although a more clearly deﬁned
end point, has been found to be associated
with environmental exposures, including lead
(Selevan et al. 2003).
Nonstandard work hours may be disturbed
by many physiologic functions and systems
that are circadian in nature (Akerstedt 1990).
Circadian rhythms normally occur in the repro-
ductive endocrine system (Frazier and Grainger
2003). Thus, hormonal disturbances, either as
a direct effect of circadian rhythm disruption
or indirectly through psychosocial stress and
altered sleep patterns, are suggested as a possible
mechanism. The effect of shift work, and circa-
dian rhythm disruption, on reproductive out-
comes is poorly understood, although advances
have been made in the development of metrics
for measuring disruption of circadian rhythm
in working populations. One such metric is the
variability of 2-sulfoxymelatonin, the urinary
metabolite of melatonin, which has been
found to be correlated with travel by female
ﬂight attendants through multiple time zones
(Grajewski et al. 2003).
To better understand the impact of shift
work and long work hours on reproductive
health, important data may be leveraged from
ongoing prospective studies. In 2001, with
NORA funding, NIOSH investigators initi-
ated a collaborative study with the Harvard
University Nurses’ Health Study II (NHS II)
research team. This study is collecting and
analyzing data from 10,000 members of the
NHS II cohort. Before this study, few occu-
pational data had been collected from the
NHS II cohort. A successful, ongoing collab-
oration was developed between NIOSH and
Harvard that will likely engender considera-
tion of the effects of other occupational expo-
sures on reproductive health.
One of the most promising prospective
studies that will add to our understanding of
reproductive health is the National Children’s
Study (NCS), a multiagency landmark study
of 100,000 children from preconception to
adulthood (National Children’s Study 2005).
NIOSH NORA team members have part-
nered with NCS planners to provide guidance
on how to include parental occupational his-
tories as part of the baseline metrics of the
cohort. This project will allow many hypothe-
ses to be tested regarding parental exposures
and their impact on congenital anomalies,
developmental delays, sexual differentiation,
puberty, and subsequent fertility.
An area that merits further exploration
through NCS and other studies is the relation-
ship between parental occupational exposures,
fetal growth, and distant postnatal health. For
example, according to the Barker hypothesis
(Khan et al. 2003; Lau and Rogers 2004), low
birth weight increases the risk of obesity,
hypertension, and cardiovascular disease during
adulthood. Because exposure to developmental
toxicants is associated with low birth weight,
research is being directed at testing the Barker
hypothesis with regard to toxicant-induced low
birth weight. Preliminary evidence indicates
that low birth weight per se (i.e., that due to
controlled underfeeding during pregnancy) is
not associated with adverse reproductive capac-
ity in the offspring (Rogers et al. 2003).
Continuing research will determine whether
toxicant-induced low birth weight has the
potential to affect reproductive capacity and
other health outcomes of offspring.
Rethinking occupational exposures merits
consideration of the emerging field of engi-
neered nanomaterials [uniformly sized materi-
als < 100 nm (1 nanometer = 10–9 meter)].
Nanotechnology is being touted as a great
opportunity for technologic advancement, but
the potential toxicologic hazards associated
with the increasing commercial applications of
nanotechnology are still being characterized
(Colvin 2003). The National Nanotechnology
Initiative, officially established in fiscal year
2001 (National Research Council 2002),
involves 17 federal agencies, including
NIOSH. The private sector is also actively
involved in nanotechnology research, and
applications for computer components, cos-
metic products, textiles, medical imaging, and
drug delivery are already in commerce or
under development (Perkel 2003, 2004).
Nanoscale zinc oxide and titanium dioxide,
for example, are both currently being incorpo-
rated into sunscreen lotions (Royal Society
and Royal Academy of Engineering 2004),
and as a result, both production workers and
consumers (including pregnant women) are
potentially exposed to these materials. Colvin
(2004) suggested that by changing the surface
properties, engineered nanoparticles can cross
cell membranes and potentially circulate in the
blood. Hence, it is theoretically possible that
nanoparticles may cross the blood–brain bar-
rier and the placenta. Because exposures to
men and women and children may already be
occurring, there is a clear need to investigate
the potential reproductive health risk of engi-
neered nanomaterials (Dreher 2004).
Another challenge in consideration of
occupational reproductive health is assess-
ment of multiple exposures. If workers are
exposed to multiple compounds that act by
the same mechanism, effects may be additive
or synergistic, even though no single exposure
occurs above occupational exposure limits
(NIOSH 2005). This concern is supported by
toxicologic studies showing additivity of
adverse reproductive effects from solvent mix-
tures (Brown-Woodman et al. 1994), anti-
androgenic fungicides (Nellemann et al. 2003),
metals and chlorinated hydrocarbons (Roegge
et al. 2004), and other mixtures. For this rea-
son, it has been standard industrial hygiene
practice to use a mixture formula to calculate a
lower acceptable occupational exposure level
when multiple exposures occur in the work-
place [American Conference of Governmental
Industrial Hygienists (ACGIH) Worldwide
2004]. More research is needed on mechanisms
of toxicity to determine when this risk assess-
ment procedure should be applied. Even more
challenging may be consideration of the effects
of physical hazards in concert with chemical
hazards; for example, whole-body vibration can
affect androgen levels just as chemical toxicants
can (Cardinale and Pope 2003). Interpreting
available information on additive and synergis-
tic effects of exposures remains a challenge for
employers, especially small businesses with lim-
ited access to industrial hygiene and toxicologic
specialists. It is incumbent on occupational
health researchers and policy makers to address
these challenges to better protect all workers.
A national occupational reproductive research agenda
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for high throughput and customized screening.
One of the most signiﬁcant issues in the regu-
lation of toxic compounds has been the gap
between the number of chemicals that are in
commerce and the number that have been
thoroughly tested for their ability to affect
reproduction and development. The reason
for this gap is that the current state-of-the-art
in toxicity testing consists of protocols in labo-
ratory animals that are time and labor inten-
sive. Even though the test species have been
selected, in part, because of their short repro-
ductive cycles, these cycles take several months
to complete, so a full assessment of a chemical
may take a year or more. There are a number
of possible ways to screen chemicals for priori-
tizing for future testing, including quantitative
structure–activity relationship predictions,
high-throughput screening for a speciﬁc bio-
logic activity, or in vitro assays that mimic one
or more critical biologic events that occur as
part of the reproductive process.
One of the impediments to using these
screening techniques is that their develop-
ment and effectiveness depend on having a
good understanding of the key biochemical
and molecular events that control reproduc-
tion and development and that may be the
targets of toxicants. Continuing advances in
our understanding of this underlying molecu-
lar control are making it possible to design
structure–activity relationship programs and
high-throughput screens that may be useful
for prioritizing compounds based on putative
mechanism of action and potency. High-
throughput screening assays are already being
used in the pharmaceutical industry, where
the process of drug development involves
screening tens of thousands of compounds at
a time for therapeutic efficacy and possible
toxicity. It is clear from these efforts that
high-throughput screening for identifying
potential toxicants is feasible (Meador et al.
2002; Waring and Ulrich 2000).
The sex steroids (androgens, estrogens, and
progestogens) have long been known to be
important to reproduction, but recent advances
in science have made it possible to create practi-
cal screening assays that have a remarkable
degree of speciﬁcity. High-throughput assays
for estrogen receptor binding are commercially
available, using recombinant forms of the
human estrogen receptors. There are a large
number of reporter gene assays for estrogen
and androgen receptor activity [Interagency
Coordinating Committee on the Validation
of Alternative Methods (ICCVAM) 2003].
Structure–activity relationship programs have
been developed for estrogens (Blair et al. 2000;
Bradbury et al. 2000; Mekenyan et al. 2000)
and androgens (Fang et al. 2003; Singh et al.
2000). These assays hold the potential to evalu-
ate the binding affinity of large numbers of
compounds, which would then be subjected to
more extensive screening. In addition to these
receptor binding assays, research is proceeding
to develop cell-based assays to identify
inhibitors of steroidogenesis, a non-receptor-
mediated mechanism of endocrine toxicity
(Hilscherova et al. 2004). Initiatives are under-
way to systematically develop in vitro assays for
all aspects of the reproductive cycle.
Because the output of the screening-level
assays can only be evaluated in a limited number
of animal study designs (all time- and resource-
intensive), there is a need to rethink the way that
we approach chemical testing. Speciﬁcally, the
assessment program for any given chemical
could be customized such that the testing is
focused on the most likely outcomes of the
potential mechanism(s) of toxicity, identiﬁed in
the screening level. This may lead to tiering of
testing, such as the U.S. EPA’s Voluntary
Children’s Chemical Evaluation Program,
which uses an iterative analysis of toxicity and
exposure information to determine when more
data are needed to adequately characterize a
chemical’s risk to children (U.S. EPA 2005).
Another area of considerable research
activity is the development of quantitative
structure–activity relationship (QSAR) soft-
ware to predict the potential of a chemical to
have a speciﬁc biologic activity, either through
comparison of its chemical structure with that
of a series of related chemicals or by using
physical chemical parameters to determine the
likelihood and afﬁnity of the chemical binding
to a particular receptor. QSAR models will
continue to be developed for screening large
numbers of compounds for their ability to
interact with speciﬁc biologic receptors.
Understanding mode of action. Much of
the basic science of toxicology is being devoted
to understanding the modes of action by which
exogenous agents affect living systems. Mode
of action information is important for a variety
of reasons, including a) supporting the validity
of predicting human risk from data generated
in animal models; b) serving as the basis for
extrapolating data from those models for mak-
ing quantitative predictions of human risk;
c) elucidating common mechanisms of action
among different toxicants, thereby supporting
additive risk assessment for mixtures; and
d) supporting the biologic plausibility of asso-
ciations between exposures and adverse effects.
Although mechanistic research is not new,
the pace of progress is likely to accelerate signiﬁ-
cantly with the advent of genomics (especially
functional genomics or “transcriptomics”) and
the related fields of proteomics and metabo-
nomics. Functional genomics involves a
genomewide evaluation of the changes in gene
expression in response to a perturbation. In
some instances the transduction of the exoge-
nous signal involves gene expression; in other
cases the gene expression represents the cell’s
attempt to regain homeostasis. Functional
genomics provides a comprehensive look at
these responses and important clues as to
modes of action, clues that are used to formu-
late hypotheses for further testing.
In reproductive toxicology, much of the
work using genomics technologies has been in
the area of endocrine disruptors. Naciff et al.
(2002) have identiﬁed the genes in the fetal rat
uterus and ovaries that are responsive to estro-
gens, as a means of cataloging the possible
candidate genes whose altered expression may
lead to the latent, persistent effects that have
been observed after developmental exposure to
potent estrogens (Naciff et al. 2004). Others
have evaluated the time course of gene expres-
sion during the estrous cycle in mice (Fertuck
et al. 2003), as a means of determining the
genomic control of this physiologic process. In
the course of this work, a number of genes
that were not previously known to be estrogen
responsive have been identiﬁed. Importantly,
it has been determined that, generally, all
binders to the estrogen receptor act in the
same manner at a molecular level (Moggs et al.
2004; Naciff et al. 2002, 2003), although the
number of compounds tested thus far is small
compared with the number of compounds
with potential to bind to the several subtypes
of estrogen receptors.
Other research has evaluated the effects of
various toxicants on patterns of gene expression
in embryos, in an attempt to elucidate mecha-
nisms of abnormal development. Hunter and
colleagues (Simmons et al. 2002) have identi-
fied a series of genes that are responsive to
chlorinated by-products of drinking water dis-
infection and that may be related to the con-
genital cardiovascular defects associated with
high-dose exposures to some of these com-
pounds. Knudsen’s laboratory (O’Hara et al.
2002) has used genomics to identify mito-
chondrial metabolism as the potential target
for mercury. Tully et al. (2004) report changes
in testicular gene expression profiles in rats
exposed to bromoacetic acid, a disinfection by-
product in drinking water.
In sum, this research area is likely to eluci-
date a number of questions relevant to charac-
terizing workplace reproductive hazards.
Because it appears that the pattern of gene
expression is characteristic of a particular
mechanism of action, this technology may be
useful in identifying agents with a common
mode of action for the purpose of conducting
cumulative risk assessment. Also, because gene
expression changes precede frank toxicity, it
may be possible to use gene expression data as
a means of predicting latent health effects.
Use of new technology for gene/environ-
ment interactions. With the publication of the
initial draft of the human genome (Inter-
national Human Genome Sequence Con-
sortium 2000; Venter et al. 2001), there has
Lawson et al.
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affecting individual responses to environmental
chemicals. The number of variants, mainly in
the form of single nucleotide polymorphisms
(SNPs), within the human genome is esti-
mated to be > 1.4 million (International SNP
Map Working Group 2001), although not all
of these SNPs are localized within functional
genes. An example of gene–environment inter-
actions influencing reproductive outcome is
the association between polymorphisms in the
paraoxonase gene, an enzyme that has been
linked to risk of preterm delivery and other
end points (Chen et al. 2004). Other examples
of polymorphisms associated with adverse
effects on reproductive functions include the
association of CYP1A1 Msp1 polymorphism,
which codes for a P450 enzyme involved in the
detoxiﬁcation of various environmental toxi-
cants, with increased risk of low birth weight
(Chen et al. 2005), and the association of
HER2 I655V polymorphism, which codes for
a transmembrane glycoprotein with tyrosine
kinase activity that is involved in regulating cel-
lular proliferation, with increased breast cancer
risk in women < 40 years of age (Montgomery
et al. 2003).
The Environmental Genome Project
(EGP) was initiated within the NIEHS in
1997 to examine how genetic differences
among individuals affect disease risk from envi-
ronmental agents. The EGP is concentrating
on approximately 200 environmentally respon-
sive genes, with primary focus on the SNP or
single-base variation that occurs at a frequency
of at least 1% of the population (Brookes
1999). There may be multiple SNPs for each
typical gene (Cargill et al. 1999); therefore, it
will be important to characterize the speciﬁc
functional change resulting from the SNP so
that an association can be made between expo-
sure to the chemical of interest, sequence varia-
tion, and altered response. The EGP will be
challenged to select which SNPs to evaluate in
field studies, which chemical exposures to
assess, and how to quantify these exposures.
Because exposure measures for most of the
chemicals of interest are limited, there is a criti-
cal need to quantify internal dose levels for
potential human reproductive toxicants.
Although many studies have reported the
association of various polymorphisms with
altered response to environmental toxins, these
studies are limited by the modest level of asso-
ciation between the polymorphism and expo-
sure (Ioannidis et al. 2001). There is also a
lack of reproducibility in many gene–environ-
ment association studies (Hirschorn and Daly
2005) that may be due to multiple risk factors
associated with the outcome and multiple
genes controlling the susceptibility (Blangero
2004). Thus, future studies will require the
careful selection of the study population and
of the candidate polymorphism(s), accurate
estimates of exposure to a toxin(s) to identify
associations (Tabor et al. 2002), and adequate
study populations to provide sufficient sta-
tistical power (Hunter 2005). In addition,
genomic studies have ethical and social impli-
cations that need to be considered, such as
insurance and employment discrimination,
stigmatization, and privacy issues in the occu-
pational setting (Burke et al. 2002).
Computational analyses. A major chal-
lenge for making use of new technologies is to
integrate and interpret genomic/proteomic/
metabanomic information with toxicologic
and epidemiologic end points. Currently,
standard reproductive health end points (e.g.,
sperm motility, hormone measures) can be
used as markers of reproductive health out-
comes in humans; however, the extent to
which changes in gene expression (proteins/
metabolites) predict adverse reproductive
effects remains to be characterized. The suc-
cess of this effort will rest on development
of well-designed toxicogenomic databases.
International and interagency efforts are
underway to this end (Mattes et al. 2004).
Communication. Developing and provid-
ing effective communication is a major chal-
lenge within the public health and occupational
health communities. Workers in multiple
industries need clear, quickly accessible infor-
mation that can advise men and women on
risks to their reproductive health. The NIOSH
NORA RHRT has collaborated with the
Hazardous Drug Working Group to update
written instructions and label warnings for cer-
tain hazardous drugs. The RHRT is also inter-
ested in ﬁnding ways to improve the quality of
material safety data sheets (MSDSs), with spe-
cial interest in improving the quality of repro-
ductive health information.
Reproductive risk communication research
is needed for the development of effective ways
to communicate with workers about occu-
pational reproductive hazards. For men, the
extent of risk minimization (the belief that men
are not susceptible to reproductive hazards)
needs to be determined. Among women, meth-
ods are needed to improve communication
about the importance of exposure reduction in
the preconception and periconception periods.
Effective hazard communication programs
translate technically complex terms from repro-
ductive health research into language that
workers can easily understand (“plain lan-
guage”). Despite extensive literature on the
comprehensibility of educational materials for
topics such as nutrition, smoking cessation,
and cancer treatment, there is little published
research on the comprehensibility of materials
used for workplace hazard communication. In
one study, 100 workers from manufacturing
industries were asked to read several MSDSs
written at the 12th grade reading level (Kolp
1993), and then their understanding of this
information was tested. Of a possible score of
100 points, comprehension scores were in the
range of 60–67, suggesting that a third of the
MSDS health and safety information was
incomprehensible to workers. One-fourth of
the adult population in the United States has
limited literacy skills (American Medical
Association 1999), and it is recommended that
health education materials should be written at
the 5th to 8th grade reading level (National
Work Group on Literacy and Health 1998).
The American National Standards Institute
(ANSI) devotes several pages of its revised stan-
dard on MSDS preparation to communication
principles, providing good general guidelines
on techniques to enhance comprehensibility
of these important documents (ANSI 2004).
The NORA RHRT conducted a session on
MSDS communication at the 2005 Society of
Toxicology Meeting to help improve repro-
ductive hazard communication.
Also needed is consensus building on how
best to classify reproductive hazard data for
occupational health communication. This
could assist occupational health and safety
professionals to use best practices when writ-
ing MSDSs or designing occupational hazard
communication programs. To account for
different levels of evidence, the Globally
Harmonized System of Classification and
Labeling of Chemicals provides three classiﬁca-
tion categories for reproductive toxicants—
known, presumed, or suspected reproductive or
developmental hazards—and also a category to
designate effects on, or via, lactation (Silk 2003;
UN Economic Commission for Europe 2003).
Detailed methods for interpreting toxicologic
and epidemiologic research are provided, and
concentration limits trigger classiﬁcation of a
mixture into each hazard category. For each of
these categories, a hazard statement written in
nontechnical language is provided. This initia-
tive emphasizes the importance of testing
communication materials for comprehensibil-
ity (Silk 2003). Development of risk-based
classiﬁcation information is preferable to a cat-
egory approach but will take consensus efforts
to implement. Future research needs to apply
methods such as these to ascertain the percep-
tions of workers with varying levels of literacy
and differences in cultural experiences and to
determine their effectiveness in promoting safe
work practices.
Research to Practice in
Occupational Reproductive
Health Research: The Case 
of Hazardous Drugs
NIOSH’s new Research to Practice (r2p) ini-
tiative is designed to transfer research ﬁndings,
technologies, and information into effective
prevention practices and products and to pro-
mote their adoption in workplaces. The goal
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injuries, and fatalities by increasing the work-
place use of effective NIOSH and NIOSH-
funded research ﬁndings.
A vibrant example of r2p implementation
is the NORA RHRT’s Hazardous Drug
Working Group activities regarding the unsafe
handling of hazardous drugs in health care set-
tings, an instance in which exposure opportu-
nity is unregulated and the hazard is high.
Scientific evidence appeared in the literature
several years ago documenting widespread
contamination of oncology clinics and phar-
macies with antineoplastic hazardous drugs in
a number of university hospitals in the United
States and Canada (Connor et al. 1999).
Although the Occupational Safety and Health
Administration (OSHA) and professional
organizations of hospital pharmacists and
oncology nurses have published safe handling
guidelines (OSHA 1986, 1995), it was appar-
ent that, despite the high potential health risk
these drugs posed to workers when handled
improperly, there was poor adherence to rec-
ommended standards of safe professional prac-
tice (Connor et al. 1999). The existing gaps in
the collective science include full toxicologic
characterization of these drugs in health care
exposure settings, industrial hygiene methods
to describe exposure, adequate risk communi-
cation to affected workers, and vigilance in
assuring and evaluating safe handling work
practices. This single example is summarized
according to the Carnegie scholarship model
of discovery, integration, application, and
teaching (Boyer 1990) in Table 1.
Discovery scholarship—that is, new
knowledge—continues to accrue and, in so
doing, suggests further information gaps
regarding these most toxic therapeutic drugs,
many of which are known carcinogens and
undisputed human reproductive and develop-
mental toxicants. Engineering scientists are col-
laborating with toxicologists on the hazardous
drug problem in a relevant example of integra-
tion scholarship, the making of connections
across disciplines. For example, the fugitive
drug particulate captured on high-efficiency
particulate air (HEPA) ﬁlters in biologic safety
cabinets appears to be volatilizing under the
high-volume air ﬂows passed over the ﬁlters.
This volatilization presents a potential exposure
to workers not currently addressed elsewhere.
There is a cascade of implications for change in
both engineering controls and work practices
if this volatilization exposure is found to be
commonplace.
The scholarship of application describes a
lively engagement between affected parties in
the sciences and the beneﬁciaries of that science
to fully use the knowledge gained from both
the discovery and integration activities. As an
example, NORA RHRT partnered with the
NORA Control Technology Team to sponsor
and support a working group to review the new
evidence regarding ongoing exposure of health
care workers to hazardous drugs and to assess
the need for change of current work recom-
mendations. The Hazardous Drug Working
Group is composed of stakeholders from all
federal government agencies and regulatory
bodies affected, health care worker unions, pro-
fessions, home care providers, drug manufac-
turers, and academia. The group reviewed new
evidence of exposure against existing OSHA
and professional practice guidelines to deter-
mine where gaps exist in compliance and the
worker knowledge base. This group produced a
NIOSH Alert (NIOSH 2004) titled “Safe
Handling of Hazardous Drugs in Healthcare,”
which served as an organizing focus for stake-
holders to brainstorm and translate this new
science base into speciﬁc work practice appli-
cations, identifying strategies to improve safe
handling and enhance worker protection.
Teaching scholarship, extending and
communicating knowledge to the affected
public, began in this r2p effort with a health
care industry “rollout” workshop in October
2004 (Alert on Reducing Occupational
Exposures to Hazardous Drugs in Healthcare:
Converting Theory to Practice, 3–5 October
2004, San Antonio, TX) to raise national
awareness about hazardous drug exposures
and provide the scientific base for the Alert.
NIOSH, OSHA, and the Joint Commission
on Accreditation of Healthcare Organizations
leadership opened the meeting to call the
attendees to action on the part of the workers
they employ. Work group members presented
sessions offering real-world practical solutions
to support attendees in applying new infor-
mation to improve their organization’s safe
handling programs.
Summary
Effectively studying the many toxicants, physi-
cal agents, and biomechanical and psychoso-
cial stressors that may constitute reproductive
hazards in the workplace is challenging.
NIOSH’s NORA RHRT has implemented
several approaches to improve occupational
reproductive research: prioritize reproductive
toxicants for further study; promote analysis of
occupational exposure assessment in reproduc-
tive health surveillance; facilitate collaboration
among epidemiologists, biologists, and toxi-
cologists; promote quality exposure assessment
in ﬁeld studies; and encourage the design and
conduct of priority occupational reproductive
studies. Here we describe new tools for screen-
ing of reproductive toxicants and for analyzing
mode of action. We recommend considering
outcomes for further study such as menopause
and latent adverse effects, as well as including
exposures such as shift work and nanomateri-
als. This report describes a broad domain of
scholarship activities where a cohesive system
of organized and aligned work activities inte-
grates 10 years of team efforts and provides
guidance for future research.
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